Cite
HARVARD Citation
Merz, C. et al. (n.d.). APG1233 is a novel hexavalent CD40 agonist acting on monocyte differentiation and macrophage-polarization and promotes increased activation of CD4+ T cells by shifting M1/M2 macrophage balance. European journal of cancer. pp. S215-S216. [Online].